Our Recommendations
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (2021)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
New Publications
- Men and HIV: evidence-based approaches and interventions (2023)
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
- Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV (2021)
- Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (2021)
- Clinical Guidelines HIV (2021)
Filter
47
Featured
Recommendations
4
New Publications
4
Language
Document type
No document type
25
Guidelines
15
Fact sheets
3
Studies & Reports
2
Manuals
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
3
Latin America and the Carribbean
2
South Africa
2
Laos
1
Africa
1
Cambodia
1
Vietnam
1
Authors & Publishers
Publication Years
Category
HIV & STI
15
Policies & Guidelines HIV & TB
3
Guidelines
2
COVID-19
1
Women & Child Health
1
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
Antiretroviral Treatment ART
47
Clinical Aspects, Treatment & Prevention
22
Treatment Guidelines HIV
10
Treatment & Prevention
6
Clinical Aspects
5
HIV testing & services
4
HIV and COVID-19
4
ART Drug Resistance
3
Opportunistic Infections
3
Access to treatment and laboratory
3
Co-Morbidities (except TB)
3
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
HIV and coinfection
2
Children & Adolescents
1
Prevention Guidelines
1
Country specific documents
1
COVID-19
1
Women
1
Prevention of mother-to-child transmission (PMTCT)
1
TB/HIV Coinfection
1
HIV service delivery
1
Accessed: 19.10.2019
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
WHO/HIV/SIP
Accessed: 28.11.2019
www.i-Base.info
Accessed: 28.11.2019
Q&A on COVID-19, HIV and antiretrovirals - Hỏi Đáp về COVID-19, HIV và thuốc antiretrovirals (ARVs)
The federally approved medical practice guidelines for HIV/AIDS are developed by panels of experts in HIV care. More information about the panels can be found in each set of guidelines.
The guidelines are available in multiple formats. The brief versions of the guidelines are compilations of the pa...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
This technical note summarizes the consolidated guidelines and adapts them to the context of Latin America and the Caribbean, in order to adequately monitor the number of people on ART. For this purpose, guidance is presented on the indicators and the methodology to know more precisely the number of...
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes.
The latest data on safety and efficacy of do...
Men experience increased risk of morbidity and mortality across all ten major contributors to poor health and continue to lag behind women regarding HIV services and other health outcomes. Globally, men now account for the majority of new HIV infections. In 2022, only 72% of men living with HIV (age...
